Advanced interstitial lung disease: Evidence-based management and clinical approach

Area of Science:

• Pulmonology
• Critical Care Medicine

Background:

• Interstitial lung disease (ILD) is a complex group of conditions with diverse clinical, physiological, and radiological features.
• Advanced ILD signifies progressive decline, impacting quality of life and necessitating specialized management strategies.
• Current guidelines lack specific focus on advanced ILD, highlighting a critical gap in patient care.

Purpose of the Study:

• To define advanced ILD and outline essential clinical considerations for its diagnosis.
• To identify key management strategies for patients with advanced ILD.
• To emphasize the importance of early lung transplantation referral.

Main Methods:

• This review synthesizes current knowledge on advanced ILD.
• It examines pathophysiologic mechanisms and common complications.
• It discusses pharmacologic and non-pharmacologic treatment modalities.

Main Results:

• Advanced ILD encompasses a range of subtypes with varied management approaches.
• Key complications include inflammation, fibrosis, pulmonary hypertension, and infections.
• Management involves tailored pharmacologic and non-pharmacologic interventions.

Conclusions:

• Prompt identification of disease progression and complications is crucial for advanced ILD management.
• Optimizing lung function and quality of life are primary goals.
• Early referral for lung transplantation is vital due to the potentially fatal nature of advanced ILD.